Metabonomic Approach to Understanding Adriamycin Resistance in Breast Cancer Cells
Since chemoresistance is a complicated and multifactorial factor in breast cancer,systematically characterize metabolic perturbation of endogenous compounds associated with drug resistance may providecandidate biomarkers or novel drug targets.The current study examined the different metabolites between senstivebreast cancer MCF-7/S and adriamycin-resistant MCF-7/Adr and their differentresponse to adriamycin.GC-TOF/MS-based metabonomic analysis revealed the different metabolic patterns between these two cell lines and the discriminatory metabolites suggested the nucleotides metabolism,glutathione biosynthesis,glucose metabolism and glycerol metabolism were reprogrammed.These
metabolomics drug resistance breast cancer nucleotides metabolism glutathione biosynthesis glucose metabolism glycerol metabolism biomarkers
Bei Cao Jiye A Guangji Wang Weibin Zha Qijin Zhao Beth S.Zha Rongrong Gu Linsheng Liu Jian Shi Xiaolan Wu Fang Zhou
Lab of Metabolomics, Key Laboratory of Drug Metabolism and Pharmacokinetics, China Pharmaceutical Un Department of Microbiology & Immunology, Virginia Commonwealth University, Richmond, Virginia, 23298
国内会议
南京
英文
162-163
2012-07-01(万方平台首次上网日期,不代表论文的发表时间)